Prognostic Value of Interleukin‐6 and High‐Sensitivity C‐Reactive Protein in Stroke Associated With Intracranial Atherosclerotic Stenosis
Journal of the American Heart Association · 2026
DOI: 10.1161/jaha.126.050279 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of the American Heart Association, 2026. Verfasst von Takao Hoshino und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology Tokyo Women's Medical University Hospital Tokyo Japan. Hauptthemen laut MEDLINE: C-Reactive Protein, Interleukin-6, Intracranial Arteriosclerosis, Stroke. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Schlaganfall
Abstract (Originalsprache)
Background
Intracranial atherosclerotic stenosis (ICAS) is a major cause of ischemic stroke with a high recurrence risk despite guideline‐based secondary prevention. Although inflammation may contribute to this residual risk, the prognostic roles of interleukin‐6 (IL‐6) and hsCRP (high‐sensitivity C‐reactive protein) in ICAS‐related stroke remain unclear.
Methods
This prospective observational study enrolled 942 patients with ischemic stroke within 1 week of onset. ICAS was defined as ≥50% stenosis/occlusion. High IL‐6 and hsCRP levels were defined using median cutoffs of ≥4.2 pg/mL and ≥2.0 mg/L, respectively. The primary end point was 1‐year major adverse cardiovascular events (MACE), including nonfatal stroke, nonfatal acute coronary syndrome, and vascular death.
Results
Of the 942 patients (mean age; 71.2 years, men; 61.3%), 262 (27.8%) had ICAS. Among patients with ICAS, elevated IL‐6 and hsCRP were each associated with higher MACE rates (IL‐6: 15.4% versus 28.8%, log‐rank P =0.012; hsCRP: 15.9% versus 28.5%, log‐rank P =0.015). After multivariate adjustment, hsCRP ≥2.0 mg/L remained independently associated with MACE (hazard ratio [HR], 2.01; 95% CI, 1.12–3.59), whereas the association for IL‐6≥4.2 pg/mL was attenuated (HR, 1.75; 95% CI, 0.95–3.23). Both biomarkers were associated with MACE in patients achieving low‐density lipoprotein cholesterol
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology Tokyo Women's Medical University Hospital Tokyo Japan.
- Department of Neurology Tokyo Women's Medical University Adachi Medical Center Tokyo Japan.
ORCID-Profile: Takao Hoshino, Takafumi Mizuno, Satoko Arai, Megumi Hosoya, Kentaro Ishizuka, Sono Toi
Zitieren
APA
Hoshino, T., Mizuno, T., Arai, S., Hosoya, M., Takahashi, S., Wako, S., Ishizuka, K., Toi, S., & Todo, K. (2026). Prognostic Value of Interleukin‐6 and High‐Sensitivity C‐Reactive Protein in Stroke Associated With Intracranial Atherosclerotic Stenosis. Journal of the American Heart Association. https://doi.org/10.1161/jaha.126.050279
Vancouver
Hoshino T, Mizuno T, Arai S, Hosoya M, Takahashi S, Wako S, et al. Prognostic Value of Interleukin‐6 and High‐Sensitivity C‐Reactive Protein in Stroke Associated With Intracranial Atherosclerotic Stenosis. Journal of the American Heart Association. 2026. doi:10.1161/jaha.126.050279
BibTeX
@article{Hoshino2026,
author = {Hoshino, Takao and Mizuno, Takafumi and Arai, Satoko and Hosoya, Megumi and Takahashi, Shuntaro and Wako, Sho and Ishizuka, Kentaro and Toi, Sono and Todo, Kenichi},
title = {Prognostic Value of Interleukin‐6 and High‐Sensitivity C‐Reactive Protein in Stroke Associated With Intracranial Atherosclerotic Stenosis},
journal = {Journal of the American Heart Association},
year = {2026},
doi = {10.1161/jaha.126.050279}
}
EUVIMED